gatifloxacin has been researched along with Pneumonia in 9 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this report was to describe a new case of gatifloxacin-associated hyperglycemia in an elderly patient and to provide a summary of case reports." | 8.83 | Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. ( Lee, AJ; Yip, C, 2006) |
| "The purpose of this report was to describe a new case of gatifloxacin-associated hyperglycemia in an elderly patient and to provide a summary of case reports." | 4.83 | Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. ( Lee, AJ; Yip, C, 2006) |
| " To consider the optimized administration method based on PK/PD theory for the elderly patients of gatifloxacin (GFLX), which was one of the oral respiratory quinolone antibacterial, Monte Carlo Simulation was conducted with community-acquired pneumonia and susceptibility data for Streptococcus pneumoniae (345 strains) collected by the second gatifloxacin surveillance study." | 3.74 | [The proper use of quinolones to the elderly patient with community-acquired pneumonia examined by Monte Carlo simulation]. ( Fukushima, K; Hirakata, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Miyazaki, Y; Morinaga, Y; Nakamura, S; Seki, M; Tashiro, T; Yamamoto, Y; Yanagihara, K, 2007) |
| "A retrospective cohort study of hospitalized adult (> or =18 years) patients admitted with Community Acquired Pneumonia (CAP) or Acute Exacerbation of Chronic Bronchitis (AECB) in a US tertiary care hospital between 7/1/01 and 12/31/04 treated with gatifloxacin or ceftriaxone during hospital admission." | 3.74 | An evaluation of the effects of gatifloxacin on glucose homeostasis. ( Hatton, RC; Onyenwenyi, AJ; Winterstein, AG, 2008) |
| "IV gatifloxacin was stepped down to oral gatifloxacin in 90." | 2.71 | Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st ( Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corrêa, JC | 1 |
| Badaró, R | 1 |
| Bumroongkit, C | 1 |
| Mera, JR | 1 |
| Dolmann, AL | 1 |
| Juárez Martínez, LG | 1 |
| Mayrinck, LR | 1 |
| Tamez, R | 1 |
| Yang, JY | 1 |
| Hoepelman, I | 1 |
| Bobba, RK | 1 |
| Arsura, EL | 1 |
| Satyanarayana, S | 1 |
| Campbell, B | 1 |
| Palmer, TR | 1 |
| Yip, C | 1 |
| Lee, AJ | 1 |
| Yanagihara, K | 1 |
| Morinaga, Y | 1 |
| Fukushima, K | 1 |
| Nakamura, S | 1 |
| Kurihara, S | 1 |
| Seki, M | 1 |
| Izumikawa, K | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Miyazaki, Y | 1 |
| Hirakata, Y | 1 |
| Tashiro, T | 1 |
| Kohno, S | 1 |
| Onyenwenyi, AJ | 1 |
| Winterstein, AG | 1 |
| Hatton, RC | 1 |
2 reviews available for gatifloxacin and Pneumonia
| Article | Year |
|---|---|
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin].
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gr | 2004 |
Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.
Topics: Age Factors; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Fluoroquinolones; Gatifloxacin | 2006 |
1 trial available for gatifloxacin and Pneumonia
| Article | Year |
|---|---|
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infect | 2003 |
6 other studies available for gatifloxacin and Pneumonia
| Article | Year |
|---|---|
Hyperglycemia in an elderly diabetic patient: drug-drug or drug-disease interaction?
Topics: Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug | 2006 |
Gatifloxacin-induced delirium and psychosis in an elderly demented woman.
Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin | 2006 |
Delirium was likely due to multiple factors, rather than gatifloxacin induced.
Topics: Aged, 80 and over; Anti-Infective Agents; Delirium; Dementia; Female; Fluoroquinolones; Gatifloxacin | 2006 |
[The proper use of quinolones to the elderly patient with community-acquired pneumonia examined by Monte Carlo simulation].
Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Gatifloxacin; Humans; | 2007 |
An evaluation of the effects of gatifloxacin on glucose homeostasis.
Topics: Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Bronchitis; Ceftriaxone; Cohort Studies; Communit | 2008 |
Gatifloxacin and moxifloxacin: two new fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; Community-Acquired Infections; Fluoroquinolones; Gastrointesti | 2000 |